Ibrahim Taraoune DIABETOLOGIST

Board Member

• Medical Society of Jordan, 1981.
• Athens Medical Society, 1982.
• Hellenic Diabetes Society, 1997.
• General Medical Council, England, 1998

Professional Experience

• 1989-Current Internist, Hygeia General Hospital.
• 1989-Current Diabetologist, Diabetic Center and Clinic, 
• Hygeia Hospital (Director Ch. ZOUPAS). 
• 2006-Current Vice Director of the Diabetic  Clinic, Hygeia Hospital

Education Experience

• XVIth International Diabetes Federation IDF Meeting, 20-25 July 1997, Helsinki Finland.
• First International Workshop on Diabetes Mellitus in  Children and adolescents under the auspices of the International Society for Pediatric and Adolescent Diabetes ISPAD, (Amman, Jordan, October 26-29, 1997).
• Annual Postgraduate Seminar on Diabetes Mellitus, organized by the 2nd University Department of Internal Medicine (November 1997).
• Annual Meeting of the European Association for the Study of οf Diabetes (EASD), (Barcelona Spain, Sept., 8-12-1998).
• 3rd International Symposium on the Diabetic Foot, The Netherlands, May 1999.
• ADA 65th Annual Scientific Sessions San Diego, USA, 2005.
• EASD Annual Meeting, Athens, Greece 2005.
• DPSG Annual Meeting, Myconos, Greece 2005.
• EASD Annual Meeting, Amsterdam, The Netherlands 2007.
• 44th EASD Annual Meeting, Rome, Italy 2008.
• 45th EASD Annual Meeting, Vienna, Austria 2009.
• 46th EASD Annual Meeting, Stockholm, Sweden 2010.
• 47th EASD Annual Meeting, Lisbon, Portugal 2011.  

Clinical Interest

• Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Gestational Diabetes, Diabetic Foot, Diabetic Neuropathy and Angiopathy

Research Interest

• Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Gestational Diabetes, Diabetic Foot, Diabetic Neuropathy and Angiopathy

• The effects of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Armstrong DG, Harkless LB, Boulton AJ. Diabet Med. 2001 Feb;18(2):133-8.
• A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ. Diabetes Care. 2001 Jan;24(1):84-8.
• Evaluation of continuous use of Real Time Glucose Monitoring (PRT), alone and combined with Insulin Pump Therapy, as a mean to normalize Glycaemic Control in IDDM. Zoupas CS, Kepaptsoglou O, Taraoune I, Giannakopoulos F, Garoutsou P, Barreto C, Vasilopoulos H, Kefaloyannis N, Kyrlaki E, Pappas A. Diabetes. June 2008;57(S1).
• One year continuous use of Real Time Glucose Monitoring combined with Insulin Pump, as a mean to normalize Glucose Variability and HbA1c in IDDM. Zoupas CS, Kepaptsoglou O, Kefaloyannis N, Taraoune I, Giannakopoulos F, Sfakianaki M, Garoutsou P, Vasilopoulos H, Kyrlaki E, Pappas A. Diabetologia. Sept. 2008;51(S1).
• Intensification of Therapy and Better Glucose Control after the Continuous Use ofReal Time Glucose Monitoring combined with Insulin Pump (PRT system) inType 1 Diabetes Melitus. Pappas AC , Kepaptzoglou O, Kyrlaki E, Taraoune I, Sfakianaki M, Garoutsou P, Vasilopoulos H, Kefaloyannis N, Zoupas CS. Diabetes. June 2009;58(S1). 
• Pump users and insulin infusion sets during financial crisis: A matter of consideration? P. Thomakos, O. Kepaptsoglou, I. Taraoune, C. Barreto, C. Zoupas. Diabetes Technology & Therapeutics. February 2015, 17(S1): A-69.
• Which factors may affect the quality of life in patients with Type 1 Diabetes Mellitus using Continuous Subcutaneous Insulin Infusion pumps? P. Thomakos, A. Mitrakou, O. Kepaptsoglou, I. Taraoune, C. Barreto, A. Pappas, C. Zoupas. Diabetes Technology & Therapeutics. February 2016, 18(S1): A-113-114.